Back to results
US 2012/0058048 A1Published application
Directed radiotherapy
OwnerWilliam Hermaninventor
Life of this patent
Estimating the term…
Abstract
The present invention relates enhanced targeting of drug delivery vehicles to vascular endothelial cells
Claims10
A composition comprising microspheres including rolling ligands that enhance binding in tumor vasculature and a therapeutic coated thereon.
A composition of matter comprising a heterofunctional ligand including a neo-vascular targeting ligand and an TNFR-1 or TNFR-2 agonist.
Dependencies are inferred from the claim text.